Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Gu

Showing results (521-530 of 1,099) with videos related to

Pageof 110
Sort By:
ASAIO Transactions|July 1, 1990
Limitation of myocardial infarct size by a right ventricular assist deviceB Y Chiang, C X Ye, Y J Gu, et al.
Oncotarget|January 6, 2017
Mitotic catastrophe and cell cycle arrest are alternative cell death pathways executed by bortezomib in rituximab resistant B-cell lymphoma cellsJuan J Gu, Gregory P Kaufman, Cory Mavis, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|September 28, 2011
Overexpression of cyclin E isoforms correlates with poor prognosis in rectal cancerY J Zhou, Y T Xie, J Gu, et al.
Yao Xue Xue Bao = Acta Pharmaceutica Sinica|October 1, 1981
[Synthesis of Nevadensin analogues and their anti-tuberculosis activity (author's transl)]C F Tang, G L Xi, K J Gu, et al.
Annals of Medicine|April 1, 1993
NORPLANT and the levonorgestrel IUD in Chinese family planning programmesB L Xiao, S J Gu, S L Wang, et al.
British Journal of Haematology|March 1, 1996
Karyotype conversion in two patients with chronic myeloid leukaemia after busulphan-induced marrow hypoplasiaY Xue, X J Zhou, F Yu, et al.
Yao Xue Xue Bao = Acta Pharmaceutica Sinica|January 1, 1989
[The dissolution rate and physical dispersion state of preparations of biphenyl dimethyl dicarboxylate (DDB)]S J Gu, W W Gao, P X Qiao, et al.
Leukemia & Lymphoma|June 1, 1999
Interleukin-10 and Gp130 cytokines in human multiple myelomaB Klein, Z Y Lu, Z J Gu, et al.
Cancer Genetics and Cytogenetics|April 13, 1999
Three measures of mutagen sensitivity in a cancer-free populationJ Gu, M L Bondy, A Sigurdson, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|March 29, 2001
Augmenting transgene expression from carcinoembryonic antigen (CEA) promoter via a GAL4 gene regulatory systemP E Koch, Z S Guo, S Kagawa, et al.
Pageof 110

Showing results (521-530 of 1,099) with videos related to

Sort By:
Pageof 110
ASAIO Transactions|July 1, 1990
Limitation of myocardial infarct size by a right ventricular assist deviceB Y Chiang, C X Ye, Y J Gu, et al.
Oncotarget|January 6, 2017
Mitotic catastrophe and cell cycle arrest are alternative cell death pathways executed by bortezomib in rituximab resistant B-cell lymphoma cellsJuan J Gu, Gregory P Kaufman, Cory Mavis, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|September 28, 2011
Overexpression of cyclin E isoforms correlates with poor prognosis in rectal cancerY J Zhou, Y T Xie, J Gu, et al.
Yao Xue Xue Bao = Acta Pharmaceutica Sinica|October 1, 1981
[Synthesis of Nevadensin analogues and their anti-tuberculosis activity (author's transl)]C F Tang, G L Xi, K J Gu, et al.
Annals of Medicine|April 1, 1993
NORPLANT and the levonorgestrel IUD in Chinese family planning programmesB L Xiao, S J Gu, S L Wang, et al.
British Journal of Haematology|March 1, 1996
Karyotype conversion in two patients with chronic myeloid leukaemia after busulphan-induced marrow hypoplasiaY Xue, X J Zhou, F Yu, et al.
Yao Xue Xue Bao = Acta Pharmaceutica Sinica|January 1, 1989
[The dissolution rate and physical dispersion state of preparations of biphenyl dimethyl dicarboxylate (DDB)]S J Gu, W W Gao, P X Qiao, et al.
Leukemia & Lymphoma|June 1, 1999
Interleukin-10 and Gp130 cytokines in human multiple myelomaB Klein, Z Y Lu, Z J Gu, et al.
Cancer Genetics and Cytogenetics|April 13, 1999
Three measures of mutagen sensitivity in a cancer-free populationJ Gu, M L Bondy, A Sigurdson, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|March 29, 2001
Augmenting transgene expression from carcinoembryonic antigen (CEA) promoter via a GAL4 gene regulatory systemP E Koch, Z S Guo, S Kagawa, et al.
Pageof 110